Does Medicare cover Ozempic?

The short answer: Medicare Part D covers Ozempic when it's prescribed for type 2 diabetes. It does not cover Ozempic for weight loss — and the new Medicare GLP-1 Bridge, which starts July 1, 2026, doesn't cover it either. But if weight loss is your goal, the Bridge does cover Wegovy and Zepbound. Here's what that distinction means for you.

Ozempic vs. Wegovy: same molecule, different Medicare rules

Ozempic and Wegovy both contain semaglutide — the same active ingredient, made by the same company (Novo Nordisk). The difference is their FDA approval:

• Ozempic — approved for type 2 diabetes. Medicare Part D covers it for that indication.
• Wegovy — approved for chronic weight management. Covered under the new Medicare GLP-1 Bridge starting July 1, 2026.

Medicare draws the line at the approved indication, not the molecule. That's why Ozempic prescribed off-label for weight loss isn't covered, while Wegovy prescribed for weight management is — starting this July.

What the GLP-1 Bridge actually covers

The Bridge is a new CMS program designed specifically for weight management. It covers three brand-name medications:

• Wegovy — injection and tablets
• Zepbound KwikPen — tirzepatide for weight management (single-dose pens and vials are not included)
• Foundayo — tablets

Ozempic is not on this list. If your goal is weight loss and you're currently paying out of pocket for Ozempic, asking your doctor about Wegovy through the Bridge may be worth a conversation — they contain the same active ingredient, and the Bridge copay is estimated at around $50 a month.

If you have type 2 diabetes

Having type 2 diabetes routes GLP-1 requests through your regular Medicare Part D plan rather than the Bridge. That's not a dead end — Part D may cover a GLP-1 for your diabetes treatment — but it's a different path with different coverage rules. Only your clinician can decide what's medically appropriate and which route makes sense for you.

If you're paying cash for Ozempic for weight loss

If you don't have type 2 diabetes and you're paying out of pocket for Ozempic off-label for weight loss, you're the person the Bridge was built for — except the covered drug is Wegovy, not Ozempic. The same active ingredient, a different prescription. A few things worth knowing:

• Self-pay use of Ozempic does not disqualify you from the Bridge — only receiving a GLP-1 through your Part D plan routes you away from it
• The Bridge assesses BMI at the time GLP-1 therapy started — if Ozempic has already helped you lose weight, your starting BMI is what counts
• Your doctor would write a new prescription for Wegovy, not Ozempic; the pharmacy handles the rest

How to talk to your doctor about switching

If you're currently on Ozempic for weight loss and want to explore Wegovy through the Bridge, a simple opening: "I've been paying cash for Ozempic for weight management. I heard Medicare's new GLP-1 Bridge covers Wegovy starting July 1 — could we discuss whether that might work for me?" The doctor packet from this site includes a prescriber reference sheet with the exact steps your doctor will need for a program they may not have seen yet.

Sources and review status: Content reviewed June 12, 2026, based on published CMS materials including the prescriber fact sheet (CMS Product No. 12235). CMS Bridge overview · CMS beneficiary information.